News
Sanofi successfully prices €1.5 billion bond issue Paris, June 17, 2025 - Sanofi announces that it has successfully priced its offering of €1.5 billion of notes across 2 tranches: €750 million ...
Paris, June 17, 2025 - Sanofi announces that it has successfully priced its offering of €1.5 billion of notes across 2 tranches: €750 million fixed-rate notes, due June 2029, bearing interest at an ...
Lina Nielsen, who was diagnosed with MS aged 17, addressed NHS healthcare professionals, local government members and those ...
French pharmaceutical giant Sanofi announced on Tuesday that Tzield, the world's first and only therapy approved by the ...
18h
Medpage Today on MSNBTK Inhibitors for Multiple SclerosisMultiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...
While the renal benefits of oral semaglutide vs placebo in the SOUL trial didn't match the effects seen with the injectable ...
In April, Verve tweaked the development of the first PCSK9 inhibitor in its programme (VERVE-101) after a trial revealed ...
GEN ranks not only the top 10 publicly traded developed of editing-based therapies, but the top five privately held companies ...
18h
The Punch on MSNNAFDAC warns Nigerians about unregistered antibiotic found in LagosThe National Agency for Food and Drugs Administration and Control has alerted the public to the discovery of an unregistered batch of Tarivid 200mg in ...
23hOpinion
Zacks Investment Research on MSN5 Large Drug Stocks That Are Poised to Ride on Sector RecoveryThe sky-high tariffs imposed by the United States and retaliatory tariffs by China and some other countries hurt global stock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results